HUM
Income statement / Annual
Last year (2024), Humana Inc.'s total revenue was $117.76 B,
an increase of 10.70% from the previous year.
In 2024, Humana Inc.'s net income was $1.21 B.
See Humana Inc.,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
FY-2015
|
| Period Ended |
12/31/2024 |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
12/31/2015 |
| Operating Revenue |
$117.76 B |
$106.37 B |
$92.87 B |
$83.06 B |
$77.16 B |
$64.89 B |
$56.91 B |
$53.77 B |
$54.38 B |
$54.29 B |
| Cost of Revenue |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Gross Profit |
$117.76 B
|
$106.37 B
|
$92.87 B
|
$83.06 B
|
$77.16 B
|
$64.89 B
|
$56.91 B
|
$53.77 B
|
$54.38 B
|
$54.29 B
|
| Gross Profit Ratio |
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
| Research and Development Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| General & Administrative Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling & Marketing Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General & Administrative Expenses |
$13.22 B
|
$12.59 B
|
$12.20 B
|
$10.12 B
|
$10.05 B
|
$7.38 B
|
$7.53 B
|
$6.42 B
|
$7.17 B
|
$7.30 B
|
| Other Expenses |
$101.98 B
|
$89.77 B
|
$76.87 B
|
$69.80 B
|
$62.12 B
|
$54.32 B
|
$46.29 B
|
$43.09 B
|
$45.47 B
|
$44.65 B
|
| Operating Expenses |
$115.20 B
|
$102.36 B
|
$89.07 B
|
$79.92 B
|
$72.17 B
|
$61.70 B
|
$53.81 B
|
$49.51 B
|
$52.64 B
|
$51.94 B
|
| Cost And Expenses |
$115.20 B
|
$102.36 B
|
$89.07 B
|
$79.92 B
|
$72.17 B
|
$61.70 B
|
$53.81 B
|
$49.51 B
|
$52.64 B
|
$51.94 B
|
| Interest Income |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Interest Expense |
$660.00 M
|
$493.00 M
|
$401.00 M
|
$326.00 M
|
$283.00 M
|
$242.00 M
|
$218.00 M
|
$242.00 M
|
$189.00 M
|
$186.00 M
|
| Depreciation & Amortization |
$968.00 M
|
$917.00 M
|
$845.00 M
|
$713.00 M
|
$616.00 M
|
$575.00 M
|
$534.00 M
|
$485.00 M
|
$465.00 M
|
$447.00 M
|
| EBITDA |
$3.53 B |
$4.93 B |
$4.65 B |
$3.86 B |
$5.60 B |
$3.77 B |
$3.63 B |
$4.75 B |
$2.21 B |
$2.79 B |
| EBITDA Ratio |
0.03
|
0.05
|
0.05
|
0.05
|
0.07
|
0.07
|
0.05
|
0.09
|
0.04
|
0.06
|
| Operating Income Ratio |
0.02
|
0.04
|
0.04
|
0.05
|
0.06
|
0.06
|
0.04
|
0.08
|
0.03
|
0.05
|
| Total Other Income/Expenses Net |
-$935.00 M
|
-$693.00 M
|
-$236.00 M
|
$271.00 M
|
-$312.00 M
|
$278.00 M
|
-$1.03 B
|
-$242.00 M
|
-$189.00 M
|
$84.00 M
|
| Income Before Tax |
$1.63 B
|
$3.32 B
|
$3.56 B
|
$3.42 B
|
$4.67 B
|
$3.47 B
|
$2.07 B
|
$4.02 B
|
$1.55 B
|
$2.43 B
|
| Income Before Tax Ratio |
0.01
|
0.03
|
0.04
|
0.04
|
0.06
|
0.05
|
0.04
|
0.07
|
0.03
|
0.04
|
| Income Tax Expense |
$413.00 M
|
$836.00 M
|
$762.00 M
|
$485.00 M
|
$1.31 B
|
$763.00 M
|
$391.00 M
|
$1.57 B
|
$938.00 M
|
$1.16 B
|
| Net Income |
$1.21 B
|
$2.49 B
|
$2.81 B
|
$2.93 B
|
$3.37 B
|
$2.71 B
|
$1.68 B
|
$2.45 B
|
$614.00 M
|
$1.28 B
|
| Net Income Ratio |
0.01
|
0.02
|
0.03
|
0.04
|
0.04
|
0.04
|
0.03
|
0.05
|
0.01
|
0.02
|
| EPS |
10.01 |
20.09 |
22.2 |
22.79 |
25.47 |
20.19 |
12.24 |
16.94 |
4.11 |
8.54 |
| EPS Diluted |
9.98 |
20 |
22.08 |
22.67 |
25.31 |
20.1 |
12.16 |
16.81 |
4.07 |
8.44 |
| Weighted Average Shares Out |
$120.57 M
|
$123.87 M
|
$126.42 M
|
$128.69 M
|
$132.20 M
|
$134.05 M
|
$137.49 M
|
$144.49 M
|
$149.37 M
|
$149.45 M
|
| Weighted Average Shares Out Diluted |
$120.87 M
|
$124.44 M
|
$127.09 M
|
$129.40 M
|
$133.01 M
|
$134.73 M
|
$138.40 M
|
$145.58 M
|
$150.92 M
|
$151.14 M
|
| Link |
|
|
|
|
|
|
|
|
|
|
